Kliewer; Steven A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kliewer; Steven A..The latest application filed is for "methods and compositions for the treatment of secretory disorders".
- Kliewer; Steven A. - Dallas TX
- Kliewer; Steven A. - Cary NC
- Kliewer; Steven A. - Research Triangle Park NC
- Kliewer; Steven A. - San Diego CA
| Patent | Date |
|---|---|
| Methods And Compositions For The Treatment Of Secretory Disorders App 20220257716 - Mangelsdorf; David J. ; et al. | 2022-08-18 |
| Use of FGF21 in methods of increasing exocrine pancreatic secretion Grant 11,318,186 - Mangelsdorf , et al. May 3, 2 | 2022-05-03 |
| Methods And Compositions For The Treatment Of Secretory Disorders App 20190201490 - Mangelsdorf; David J. ; et al. | 2019-07-04 |
| Orphan Nuclear Receptor App 20120283412 - Kliewer; Steven A. ; et al. | 2012-11-08 |
| Orphan nuclear receptor Grant 8,221,991 - Kliewer , et al. July 17, 2 | 2012-07-17 |
| Orphan Nuclear Receptor App 20110059478 - Kliewer; Steven A. ; et al. | 2011-03-10 |
| Orphan Nuclear Receptor App 20080096239 - Kliewer; Steven A. ; et al. | 2008-04-24 |
| Pregnane X receptor method Grant 7,238,491 - Kliewer , et al. July 3, 2 | 2007-07-03 |
| Novel members of the steroid/thyroid superfamily and uses therefor App 20060154335 - Evans; Ronald M. ; et al. | 2006-07-13 |
| Multimeric forms of members of the steroid/thyroid superfamily of receptors Grant 7,038,022 - Evans , et al. May 2, 2 | 2006-05-02 |
| Use of FXR ligands Grant 6,984,650 - Haffner , et al. January 10, 2 | 2006-01-10 |
| Nucleic acids encoding peroxisome proliferator-activated receptor Grant 5,861,274 - Evans , et al. January 19, 1 | 1999-01-19 |
| NCAGE Code | 4KAZ5 | KLIEWER STEVEN A |
| CAGE Code | 4KAZ5 | KLIEWER, STEVEN A |
| DUNS | 785564852 | KLIEWER, STEVEN A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 